Aussie duo find global consumers for Indian generics

MUMBAI: Remember Ron the rodeo cowboy from the Oscar-winning film Dallas Buyers Club? The biopic portrayed the story of Ron Woodroof, an AIDS patient in the mid-1980s who signed up for an experimental AIDS treatment movement. He smuggled unapproved drugs into Texas for treating his symptoms and distributed them to fellow patients at a time when the disease was highly stigmatised. There’s now an Australian parallel, of sorts, with an Indian twist. Australi

Generic hepatitis C drugs continue to produce high cure rates

Treatment with generic versions of direct-acting antiviral drugs continues to produce similar cure rates to those reported in clinical trials, Dr James Freeman reported last week at the International Liver Congress in Amsterdam. Dr James Freeman, an Australian general practitioner based in Hobart, Tasmania, was reporting on the outcomes of people with hepatitis C who imported generic versions of direct-acting antivirals manufactured in India and elsewhere

October 1: A Momentous Day for Many People Living with Hepatitis C in New Zealand

From October 1, GPs around New Zealand will start prescribing life-changing medication to many of the 50,000 people living with hepatitis C in New Zealand. Viekira Pak, a breakthrough treatment which was previously out of reach to ordinary New Zealanders, is now fully funded by Pharmac. The drug treats people with hepatitis C genotype 1 who have compensated disease, which is more than half of all New Zealanders living with the virus. Renowned liver spe

Hep C ‘viral time bomb’ can be defused, says doctor who set up real-life Dallas Buyers Club operation

It is financially feasible to defuse the hepatitis C "viral time bomb" affecting 150 million people worldwide, an international conference will hear on Saturday. The disease is one of the five major causes of infectious illness deaths in the world, along with malaria, TB, HIV, and hepatitis B. It kills 500,000 people a year, the World Health Organisation estimates, and prevents millions more from leading productive lives. Yet, only one in 300 of thos...